Steven Jon Russell - 02 Sep 2025 Form 4 Insider Report for Beta Bionics, Inc. (BBNX)

Role
Chief Medical Officer
Signature
/s/ Stephen Feider, Attorney-in-Fact
Issuer symbol
BBNX
Transactions as of
02 Sep 2025
Transactions value $
-$19,146
Form type
4
Filing time
04 Sep 2025, 18:45:12 UTC
Previous filing
04 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Russell Steven Jon Chief Medical Officer C/O BETA BIONICS, INC., 11 HUGHES, IRVINE /s/ Stephen Feider, Attorney-in-Fact 03 Sep 2025 0002051384

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBNX Common Stock Sale -$19.1K -1.02K -1.41% $18.86 71K 02 Sep 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
F2 The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.